Gabelli Funds LLC F Star Therapeutics, Inc. Transaction History

Gabelli Funds LLC

  • $12.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$4.09 - $6.86 $50,217 - $84,227
12,278 Added 6.38%
204,651 $1.29 Million
Q3 2022

Nov 10, 2022
BUY
$5.41 - $6.74 $127,378 - $158,693
23,545 Added 13.95%
192,373 $985,000
Q2 2022

Aug 12, 2022
BUY
$2.18 - $6.39 $368,045 - $1.08 Million
168,828 New
168,828 $1.06 Million

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email